Evidence map›Paper›PMID 33693989›Full record

ReviewCurrent pain and headache reports2021

Disinfectants In Interventional Practices.

Mayank Aranke, Roya Moheimani, Melissa Phuphanich, Alan D Kaye, Anh L Ngo, Omar Viswanath, Jared Herman

Open access · bronzeAbstract readReview
In one paragraph

Review in Current pain and headache reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Antiviral activity of contact lens care solutions and rub-and-rinse regimen against adenovirus.Optometry and vision science : official publication of the American Academy of Optometry · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Frontiers in medicine · 2024
    Article
  10. The impacts of masks and disinfectants on migraine patients in the COVID-19 pandemic.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Mayank ArankeDepartment of Anesthesiology, University of Texas Health Science Center, Houston, TX, USA.
Roya MoheimaniDepartment of Physical Medicine and Rehabilitation, VA Greater Los Angeles Health Care System, Los Angeles, CA, USA.
Melissa PhuphanichDepartment of Physical Medicine and Rehabilitation, VA Greater Los Angeles Health Care System, Los Angeles, CA, USA.
Alan D KayeDepartment of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Anh L NgoHarvard Medical School, Boston, MA, USA.
Omar ViswanathDepartment of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Jared HermanDepartment of Anesthesiology, Mount Sinai Medical Center, Alton Road Miami Beach, FL, 4300, USA. hermanajared@gmail.com.ORCID http://orcid.org/0000-0002-3459-2791
Harvard University · USVA Greater Los Angeles Healthcare System · USCreighton University · USLouisiana State University Health Sciences Center New Orleans · USMount Sinai Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review aims to provide relevant, aggregate information about a variety of disinfectants and antiseptics, along with potential utility and limitations. While not exhaustive, this review's goal is to add to the body of literature available on this topic and give interventional providers and practitioners an additional resource to consider when performing procedures. RECENT

findingsIn the current SARS-CoV2 epidemiological environment, infection control and costs associated with healthcare-associated infections (HAIs) are of paramount importance. Even before the onset of SARS-CoV2, HAIs affected nearly 2million patients a year in the USA and resulted in nearly 90,000 deaths, all of which resulted in a cost to hospitals ranging from US$28 billion to 45 billion. The onset SARS-CoV2, though not spread by an airborne route, has heightened infection control protocols in hospitals and, as such, cast a renewed focus on disinfectants and their utility across different settings and organisms. The aim of this review is to provide a comprehensive overview of disinfectants used in the inpatient setting.

Indexed as

DisinfectantsChlorine CompoundsCross InfectionEthanolFormaldehydeGlutaralHumansHydrogen PeroxideIodophorsOxidesPeracetic AcidPhenolPovidone-IodineQuaternary Ammonium CompoundsSodium HypochloriteTriazinesChlorine Compoundschlorine dioxideDisinfectantsEthanolFormaldehydeGlutaralHydrogen PeroxideIodophorsOxidesPeracetic AcidPhenolPovidone-IodineQuaternary Ammonium CompoundsSodium Hypochloritesuperoxidized waterTriazinestrocloseneDisinfectantsHealthcare-associated infectionsInpatientInterventional practicesSARS-COV2

Identifiers

PMID33693989
PMCPMC7946573
OpenAlexW3134318927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.